679 related articles for article (PubMed ID: 23782950)
21. Total thyroidectomy (Tx) versus thionamides (antithyroid drugs) in patients with moderate-to-severe Graves' ophthalmopathy - a 1-year follow-up: study protocol for a randomized controlled trial.
Brammen L; Riss P; Lukas J; Gessl A; Dunkler D; Li S; Leisser A; Rezar-Dreindl S; Eibenberger K; Selberherr A; Scheuba C; Papp A
Trials; 2018 Sep; 19(1):495. PubMed ID: 30219088
[TBL] [Abstract][Full Text] [Related]
22. Effect of Selenium Supplementation on Recurrent Hyperthyroidism Caused by Graves' Disease: A Prospective Pilot Study.
Wang L; Wang B; Chen SR; Hou X; Wang XF; Zhao SH; Song JQ; Wang YG
Horm Metab Res; 2016 Sep; 48(9):559-64. PubMed ID: 27392116
[TBL] [Abstract][Full Text] [Related]
23. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy.
Laurberg P; Bournaud C; Karmisholt J; Orgiazzi J
Eur J Endocrinol; 2009 Jan; 160(1):1-8. PubMed ID: 18849306
[TBL] [Abstract][Full Text] [Related]
24. Graves' Disease Pharmacotherapy in Women of Reproductive Age.
Prunty JJ; Heise CD; Chaffin DG
Pharmacotherapy; 2016 Jan; 36(1):64-83. PubMed ID: 26799350
[TBL] [Abstract][Full Text] [Related]
25. [Hyperthyroidism in Graves' disease--antithyroid drug treatment].
Schumm-Draeger PM
Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():41-5. PubMed ID: 10355049
[TBL] [Abstract][Full Text] [Related]
26. Graves' Disease: Can It Be Cured?
Wiersinga WM
Endocrinol Metab (Seoul); 2019 Mar; 34(1):29-38. PubMed ID: 30912336
[TBL] [Abstract][Full Text] [Related]
27. Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study.
Glinoer D; de Nayer P; Bex M;
Eur J Endocrinol; 2001 May; 144(5):475-83. PubMed ID: 11331213
[TBL] [Abstract][Full Text] [Related]
28. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.
Laurberg P; Wallin G; Tallstedt L; Abraham-Nordling M; Lundell G; Tørring O
Eur J Endocrinol; 2008 Jan; 158(1):69-75. PubMed ID: 18166819
[TBL] [Abstract][Full Text] [Related]
29. Antithyroid drugs in Graves' hyperthyroidism: differences between "block and replace" and "titration" regimes in frequency of euthyroidism and Graves' orbitopathy during treatment.
Žarković M; Wiersinga W; Perros P; Bartalena L; Donati S; Okosieme O; Morris D; Fichter N; Lareida J; Daumerie C; Burlacu MC; Kahaly GJ; Pitz S; Beleslin B; Ćirić J; Ayvaz G; Konuk O; Törüner FB; Salvi M; Covelli D; Curro N; Hegedüs L; Brix T;
J Endocrinol Invest; 2021 Feb; 44(2):371-378. PubMed ID: 32524368
[TBL] [Abstract][Full Text] [Related]
30. Antithyroid drug and Graves' hyperthyroidism. Significance of treatment duration and TRAb determination on lasting remission.
García-Mayor RV; Páramo C; Luna Cano R; Pérez Mendez LF; Galofré JC; Andrade A
J Endocrinol Invest; 1992 Dec; 15(11):815-20. PubMed ID: 1283984
[TBL] [Abstract][Full Text] [Related]
31. Hyperthyroidism. Current treatment guidelines.
Gittoes NJ; Franklyn JA
Drugs; 1998 Apr; 55(4):543-53. PubMed ID: 9561343
[TBL] [Abstract][Full Text] [Related]
32. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
Alexander EK; Larsen PR
J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
[TBL] [Abstract][Full Text] [Related]
33. Selenium in the Treatment of Graves' Hyperthyroidism and Eye Disease.
Lanzolla G; Marinò M; Marcocci C
Front Endocrinol (Lausanne); 2020; 11():608428. PubMed ID: 33574798
[TBL] [Abstract][Full Text] [Related]
34. Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves' disease patients during methimazole treatment.
Gallo D; Bruno A; Gallazzi M; Cattaneo SAM; Veronesi G; Genoni A; Tanda ML; Bartalena L; Passi A; Piantanida E; Mortara L
Front Endocrinol (Lausanne); 2023; 14():1145811. PubMed ID: 37124743
[TBL] [Abstract][Full Text] [Related]
35. Antithyroid drug regimen for treating Graves' hyperthyroidism.
Abraham P; Avenell A; Watson WA; Park CM; Bevan JS
Cochrane Database Syst Rev; 2005 Apr; (2):CD003420. PubMed ID: 15846664
[TBL] [Abstract][Full Text] [Related]
36. Antithyroid drug regimen for treating Graves' hyperthyroidism.
Abraham P; Avenell A; Watson WA; Park CM; Bevan JS
Cochrane Database Syst Rev; 2004; (2):CD003420. PubMed ID: 15106202
[TBL] [Abstract][Full Text] [Related]
37. Hyperthyroidism.
Chaker L; Cooper DS; Walsh JP; Peeters RP
Lancet; 2024 Feb; 403(10428):768-780. PubMed ID: 38278171
[TBL] [Abstract][Full Text] [Related]
38. A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment.
Reinwein D; Benker G; Lazarus JH; Alexander WD
J Clin Endocrinol Metab; 1993 Jun; 76(6):1516-21. PubMed ID: 8501160
[TBL] [Abstract][Full Text] [Related]
39. Total versus near-total thyroidectomy in Graves' disease and their outcome on postoperative transient hypoparathyroidism: study protocol for a randomized controlled trial?
Maschuw K; Schlosser K; Lubbe D; Nies C; Bartsch DK
Trials; 2012 Dec; 13():234. PubMed ID: 23216901
[TBL] [Abstract][Full Text] [Related]
40. [Treatment with inorganic iodine for Graves' hyperthyroidism].
Noh JY; Chino T; Ito K
Nihon Rinsho; 2006 Dec; 64(12):2269-73. PubMed ID: 17154090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
